Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Low level laser therapy is effective and safe for various skin and hair conditions.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Essential oils may help hair health but lack strong scientific proof and can cause allergic reactions.

Histone modification is key in treating chronic inflammatory skin diseases.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

People with alopecia areata may have a higher risk of blood clots.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

No cure exists for alopecia areata, and treatments are personalized.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Skin issues can indicate immune system problems.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Topical tofacitinib is effective and safe for treating alopecia areata.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

JAK inhibitors offer new hope for treating severe alopecia areata.

Interleukin-15 can help hair growth and protect hair follicles.

Vitamin A affects hair loss and immune response in alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.